Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

5-HT2A receptor -1438 G/A polymorphism and serotonergic antidepressant-induced sexual dysfunction in male patients with major depressive disorder: a prospective exploratory study.

Liang CS, Ho PS, Chiang KT, Su HC.

J Sex Med. 2012 Aug;9(8):2009-16. doi: 10.1111/j.1743-6109.2012.02769.x. Epub 2012 May 21.

PMID:
22612784
2.

The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.

Sung SC, Haley CL, Wisniewski SR, Fava M, Nierenberg AA, Warden D, Morris DW, Kurian BT, Trivedi MH, Rush AJ; CO-MED Study Team.

J Clin Psychiatry. 2012 Jul;73(7):967-76. doi: 10.4088/JCP.11m07043. Epub 2012 May 29.

PMID:
22687487
3.

Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.

Masiran R, Sidi H, Mohamed Z, Mohd Nazree NE, Nik Jaafar NR, Midin M, Das S, Mohamed Saini S.

J Sex Med. 2014 Apr;11(4):1047-1055. doi: 10.1111/jsm.12452. Epub 2014 Feb 18.

PMID:
24533444
4.

Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial.

Nurnberg HG, Hensley PL, Heiman JR, Croft HA, Debattista C, Paine S.

JAMA. 2008 Jul 23;300(4):395-404. doi: 10.1001/jama.300.4.395.

PMID:
18647982
5.

The effect of vilazodone on sexual function during the treatment of major depressive disorder.

Clayton AH, Kennedy SH, Edwards JB, Gallipoli S, Reed CR.

J Sex Med. 2013 Oct;10(10):2465-76. doi: 10.1111/jsm.12004. Epub 2012 Dec 6.

PMID:
23216998
6.
7.

Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.

Qesseveur G, Petit AC, Nguyen HT, Dahan L, Colle R, Rotenberg S, Seif I, Robert P, David D, Guilloux JP, Gardier AM, Verstuyft C, Becquemont L, Corruble E, Guiard BP.

Neuropharmacology. 2016 Jun;105:142-153. doi: 10.1016/j.neuropharm.2015.12.022. Epub 2016 Jan 4.

PMID:
26764241
8.

5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients.

Kato M, Zanardi R, Rossini D, De Ronchi D, Okugawa G, Kinoshita T, Colombo C, Serretti A.

Psychiatry Res. 2009 May 15;167(1-2):97-105. doi: 10.1016/j.psychres.2007.12.012. Epub 2009 Apr 10.

PMID:
19361869
9.

Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram.

Choi MJ, Kang RH, Ham BJ, Jeong HY, Lee MS.

Neuropsychobiology. 2005;52(3):155-62. Epub 2005 Aug 25.

PMID:
16127283
10.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
11.

Sexual function during long-term duloxetine treatment in patients with recurrent major depressive disorder.

Montejo AL, Perahia DG, Spann ME, Wang F, Walker DJ, Yang CR, Detke MJ.

J Sex Med. 2011 Mar;8(3):773-82. doi: 10.1111/j.1743-6109.2010.02113.x. Epub 2010 Nov 22.

PMID:
21091877
12.

Summary of findings from the FDA regulatory science forum on measuring sexual dysfunction in depression trials.

Kronstein PD, Ishida E, Khin NA, Chang E, Hung HM, Temple RJ, Yang P.

J Clin Psychiatry. 2015 Aug;76(8):1050-9. doi: 10.4088/JCP.14r09699. Review.

PMID:
26335083
13.

Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded, prospective study.

Han C, Wang SM, Kwak KP, Won WY, Lee H, Chang CM, Tang TC, Pae CU.

J Psychiatr Res. 2015 Jul-Aug;66-67:84-94. doi: 10.1016/j.jpsychires.2015.04.020. Epub 2015 May 5.

PMID:
26013203
14.

Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.

Strohmaier J, Wüst S, Uher R, Henigsberg N, Mors O, Hauser J, Souery D, Zobel A, Dernovsek MZ, Streit F, Schmäl C, Kozel D, Placentino A, Farmer A, McGuffin P, Aitchison KJ, Rietschel M.

World J Biol Psychiatry. 2011 Oct;12(7):528-38. doi: 10.3109/15622975.2011.559270. Epub 2011 Mar 9.

15.

Desvenlafaxine 50 and 100 mg/d versus placebo for the treatment of major depressive disorder: a phase 4, randomized controlled trial.

Clayton AH, Tourian KA, Focht K, Hwang E, Cheng RF, Thase ME.

J Clin Psychiatry. 2015 May;76(5):562-9. doi: 10.4088/JCP.13m08978.

PMID:
25375652
16.

Venlafaxine or a second SSRI: Switching after treatment failure with an SSRI among depressed inpatients: a retrospective analysis.

Barak Y, Swartz M, Baruch Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1744-7. doi: 10.1016/j.pnpbp.2011.06.007. Epub 2011 Jun 24.

PMID:
21722691
17.

An evaluation of sexual functioning in employed outpatients with major depressive disorder treated with desvenlafaxine 50 mg or placebo.

Clayton AH, Reddy S, Focht K, Musgnung J, Fayyad R.

J Sex Med. 2013 Mar;10(3):768-76. doi: 10.1111/j.1743-6109.2012.02899.x. Epub 2012 Aug 20.

PMID:
22905811
18.

Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.

Lam RW, Lönn SL, Despiégel N.

Int Clin Psychopharmacol. 2010 Jul;25(4):199-203. doi: 10.1097/YIC.0b013e32833948d8.

PMID:
20357664
19.

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.

Eur Neuropsychopharmacol. 2004 Dec;14(6):457-70.

PMID:
15589385
20.

Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.

Hewett K, Gee MD, Krishen A, Wunderlich HP, Le Clus A, Evoniuk G, Modell JG.

J Psychopharmacol. 2010 Aug;24(8):1209-16. doi: 10.1177/0269881109106953. Epub 2009 Nov 25.

PMID:
19939870

Supplemental Content

Support Center